Literature DB >> 29249807

Viral subversion of B cell responses within secondary lymphoid organs.

Mirela Kuka1, Matteo Iannacone1.   

Abstract

Antibodies play a crucial role in virus control. The production of antibodies requires virus-specific B cells to encounter viral antigens in lymph nodes, become activated, interact with different immune cells, proliferate and enter specific differentiation programmes. Each step occurs in distinct lymph node niches, requiring a coordinated migration of B cells between different subcompartments. The development of multiphoton intravital microscopy has enabled researchers to begin to elucidate the precise cellular and molecular events by which lymph nodes coordinate humoral responses. This Review discusses recent studies that clarify how viruses interfere with antibody responses, highlighting how these mechanisms relate to our topological and temporal understanding of B cell activation within secondary lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29249807      PMCID: PMC7237239          DOI: 10.1038/nri.2017.133

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  104 in total

1.  Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position.

Authors:  Karin Reif; Eric H Ekland; Lars Ohl; Hideki Nakano; Martin Lipp; Reinhold Förster; Jason G Cyster
Journal:  Nature       Date:  2002-03-07       Impact factor: 49.962

Review 2.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

3.  Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells.

Authors:  Tobias Junt; E Ashley Moseman; Matteo Iannacone; Steffen Massberg; Philipp A Lang; Marianne Boes; Katja Fink; Sarah E Henrickson; Dmitry M Shayakhmetov; Nelson C Di Paolo; Nico van Rooijen; Thorsten R Mempel; Sean P Whelan; Ulrich H von Andrian
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

4.  Bisphosphonates target B cells to enhance humoral immune responses.

Authors:  Elena Tonti; Nereida Jiménez de Oya; Gabriele Galliverti; E Ashley Moseman; Pietro Di Lucia; Angelo Amabile; Stefano Sammicheli; Marco De Giovanni; Laura Sironi; Nicolas Chevrier; Giovanni Sitia; Luigi Gennari; Luca G Guidotti; Ulrich H von Andrian; Matteo Iannacone
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

Review 5.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

6.  B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity.

Authors:  E Ashley Moseman; Matteo Iannacone; Lidia Bosurgi; Elena Tonti; Nicolas Chevrier; Alexei Tumanov; Yang-Xin Fu; Nir Hacohen; Ulrich H von Andrian
Journal:  Immunity       Date:  2012-03-01       Impact factor: 31.745

7.  Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.

Authors:  R G Caldwell; R C Brown; R Longnecker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression.

Authors:  P Borrow; C F Evans; M B Oldstone
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle.

Authors:  M B McChesney; J H Kehrl; A Valsamakis; A S Fauci; M B Oldstone
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

10.  Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Authors:  Susan Moir; Angela Malaspina; Oxana K Pickeral; Eileen T Donoghue; Joshua Vasquez; Natalie J Miller; Surekha R Krishnan; Marie A Planta; John F Turney; J Shawn Justement; Shyamasundaran Kottilil; Mark Dybul; JoAnn M Mican; Colin Kovacs; Tae-Wook Chun; Charles E Birse; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more
  11 in total

1.  The Suppressive Attitude of Inflammatory Monocytes in Antiviral Antibody Responses.

Authors:  Eleonora Sala; Mirela Kuka
Journal:  Viral Immunol       Date:  2020-02-06       Impact factor: 2.257

Review 2.  The role of type I interferons in CD4+ T cell differentiation.

Authors:  Mirela Kuka; Marco De Giovanni; Matteo Iannacone
Journal:  Immunol Lett       Date:  2019-02-13       Impact factor: 3.685

Review 3.  Imaging viral infection in vivo to gain unique perspectives on cellular antiviral immunity.

Authors:  Sophia M Vrba; Heather D Hickman
Journal:  Immunol Rev       Date:  2021-11-18       Impact factor: 10.983

4.  PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection.

Authors:  Loghman Salimzadeh; Nina Le Bert; Charles-A Dutertre; Upkar S Gill; Evan W Newell; Christian Frey; Magdeleine Hung; Nikolai Novikov; Simon Fletcher; Patrick Tf Kennedy; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2018-08-07       Impact factor: 14.808

5.  Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections.

Authors:  Tadaki Suzuki; Yuko Sato; Kaori Sano; Takeshi Arashiro; Harutaka Katano; Noriko Nakajima; Masayuki Shimojima; Michiyo Kataoka; Kenta Takahashi; Yuji Wada; Shigeru Morikawa; Shuetsu Fukushi; Tomoki Yoshikawa; Masayuki Saijo; Hideki Hasegawa
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

6.  Host protein chaperones, RNA helicases and the ubiquitin network highlight the arms race for resources between tombusviruses and their hosts.

Authors:  Peter D Nagy
Journal:  Adv Virus Res       Date:  2020-07-07       Impact factor: 9.937

7.  Circulating and intrahepatic antiviral B cells are defective in hepatitis B.

Authors:  Alice R Burton; Laura J Pallett; Laura E McCoy; Kornelija Suveizdyte; Oliver E Amin; Leo Swadling; Elena Alberts; Brian R Davidson; Patrick Tf Kennedy; Upkar S Gill; Claudia Mauri; Paul A Blair; Nadege Pelletier; Mala K Maini
Journal:  J Clin Invest       Date:  2018-08-09       Impact factor: 19.456

Review 8.  Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization.

Authors:  Ning Wang; Minnan Chen; Ting Wang
Journal:  J Control Release       Date:  2019-05-03       Impact factor: 9.776

Review 9.  Immunogenicity of Protein Therapeutics: A Lymph Node Perspective.

Authors:  Kristy Fu; Kylie March; Aikaterini Alexaki; Giulia Fabozzi; Eirini Moysi; Constantinos Petrovas
Journal:  Front Immunol       Date:  2020-05-14       Impact factor: 7.561

10.  Spatiotemporal regulation of type I interferon expression determines the antiviral polarization of CD4+ T cells.

Authors:  Mirela Kuka; Matteo Iannacone; Marco De Giovanni; Valeria Cutillo; Amir Giladi; Eleonora Sala; Carmela G Maganuco; Chiara Medaglia; Pietro Di Lucia; Elisa Bono; Claudia Cristofani; Eleonora Consolo; Leonardo Giustini; Alessandra Fiore; Sarah Eickhoff; Wolfgang Kastenmüller; Ido Amit
Journal:  Nat Immunol       Date:  2020-02-17       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.